Home » Industry news

Unveiling the Next Generation of Injection Molding Machines: Faster,

Author:gly    Date: 2024-09-30    

Smarter, and More Efficient - injection moldable plastics

The tolerance requirements for the medical sector over the last decade has got increasingly stricter. Processing stability, dimensional accuracy and repeatability are critical. Medical devices often comprise multiple components. If just one element is out of tolerance, the device might not meet the performance expectations. Comprehensive quality control and traceability of parts production are essential for minimising risks.

Medical/Life Science micro-moulding is another key sector. Often using a smaller tonnage machine, the limit of what can be moulded can be as light as 0.0003g, with walls as thin as 0.01mm and dimensional tolerances to ±0.005mm

Temperature control technology plays a pivotal role in plastic injection moulding processes, ensuring consistent product quality and production efficiency. Temperature control and stability have also a direct effect on cycle times and output. Manufacturers’ economic success depends to a high degree on the development of reliable production, and the ability to efficiently control and maintain the right process temperatures within the various stages of the process is critical to achieve this.

Image

Engaging with a partner that knows the inside and out of process temperature control can help in every step of the away from surveying the sites to understanding where efficiencies can be made – recommending bespoke, fully packaged, process-designed chillers and TCUs based on tried and tested processes.

Dave Palmer, general manager for UK at ICS Cool Energy shares how to optimise plastic moulding with the latest temperature control technologies.

In the continuously changing environment, the manufacturers face many challenges embracing and understanding the new technology, wanting to provide customers with the best quality products while also reducing their operating costs. The fact that around 60% of a plants’ total lifecycle cost can be attributed to process cooling and refrigeration systems, makes it a vital investment that shouldn’t be overlooked.

It depends on the application. Typically they will be medical grade plastics, which are biocompatible and suitable for products such as MRI casings, prosthetics etc. Some applications will need a higher melting point, others sterility, tensile strength or anti-corrosive properties.

Medical manufacturers that create their own GMP documentations benefit from having a consistent tool to track the qualification of all associated equipment, including mould tools and automation solutions.  This makes it much easier to manage defined steps for design, installation, operational and production Qualifications and Validations.

We are extremely excited to share with visitors all of the latest company developments and our application-specific medical expertise, including our in-house automation offerings, our expansion in Ireland and how this supports the medical/life sciences community, plus how processors can increase productivity and machine availability.

LSR is increasingly used due to its safety, durability, temperature and chemical resistance and biocompatibility. The material is often used in baby-care products, as well as the medical industry for syringes, catheters and hearing aids. It is even feasible to combine LSR and thermoplastic moulding in one cleanroom moulding cell, allowing medical moulders to switch between the two.

Qualification forms part of the overarching validation masterplan (VMP). However, it’s just one of the verticals that feeds into the wider Validation process. There are no Qualification or Validation shortcuts. And with no standardised GMP documentation formats to follow, there are always subtle style differences. Yet, it’s good practice to keep this documentation as tight as possible, ensuring the content is unambiguous. Detailed but of a manageable size, without deviating from the original design qualification.

To comply with the FDA, GMP Annex 1 and CFR Part 211 requirements, the equipment used in the manufacture, processing, packing or holding of a drug product needs to be of an appropriate design, adequate size and suitably located.

Across the industries and applications like medical manufacturing where precision, product consistency and process repeatability are especially vital, there is a growing demand for higher energy-efficiency and reducing cycle times.

To support these efforts, Sumitomo (SHI) Demag is continuing to develop an IoT dashboard to facilitate this data analysis and visualisation, transfer and storage of know-how, as well as maintenance planning and prediction. Within this assistance system, additional autonomous and interconnected functions are being conceived to provide valuable insight into the machine performance and different production variables.

We can help customers by qualifying the equipment sold against the defined parameters specified. To make the entire Validation process easier for customers we can provide high quality consultancy at the outset of any project, drawing in all stakeholders when scoping out the machine design and user requirements specifications (URS). This helps to avoid over-specifying equipment or providing machinery that will never meet the processing tolerance requirements.

Image

The choice of moulding machinery selected for cleanrooms is generally customer-specific. Where medical components need to be manufactured and packed in a self-contained cleanroom environment to meet ISO Class 7 or 8 standards and comply with any GMP Annex 1 and FDA regulations, a fully configured all-electric injection moulding machine is typically the best option.

It should be noted that over committing to a cleanroom classification could leave medical manufacturers exposed to unwarranted compliance requirements that, once approved, they must continue to adhere to. Sometimes effective ventilation is all that’s required. Yet, for sterile medicinal products, the requirements - defined by Annex 1 of the EU and PIC/S GMPs – are now even more stringent.

The development of process optimisation systems, integrating material and knowledge with simulation tools is probably the most exciting development on the horizon. This will enable processors to observe advanced settings and capture deeper processing insights. Our ultimate vision is an intelligent machine that can independently make predictions about part quality, machine wear and failures and deliver optimisations online. Enabling greater process consistency, enhanced product quality and for real-time machine maintenance to be adjusted accordingly.

Additionally, our company’s energy recovery system offers increased capacity. This not only improves efficiency, but also increases the longevity of the electrical components. Improving the temperature control of the spindles, motors and inverters all contribute to the safe machine operation, even in the most demanding applications.

There are also a number of velocity and injection power features that can be overlooked. However, when used correctly and repeatably by moulding operatives, it results in faster cycle times and more stable start-ups. Training and field site support can be really valuable to moulders seeking higher productivity.

High-precision direct drive technology ensures more precision and repeatability. The result -  higher quality medical components. Our Medical Package direct drives are known for being clean, cool, fast and quiet. These drive systems are tailored to the applications, which lowers energy consumption and also results in less heat having to be dissipated from air-conditioned environments. All of these features help to reduce operating costs.

As a true global medical team, it’s essential that we continue to foster greater collaboration. This sharing of project successes leads to global partnerships that are so pivotal to a responsive market aligned to future medical needs. Being support by trusted partners is proven to yield the strongest and fastest results.

Additionally, the accompanying documentation can get really complex. Predominantly due to liability risks. With all medical packages, Sumitomo (SHI) Demag issues the Qualification documentation on installation. These files are signed and sent from the location where the machine order was fulfilled.

With these new pumps, operators gain control over temperature differentials (ΔT) across the mould. Once the desired temperature is achieved, operators can configure the desired ΔT and this will adjust pump speed accordingly. This dynamic adjustment isn't just a solution to demand for heightened precision in plastic moulding, it's a game-changer that reduces power consumption by between 50 and 90% at the pump level, depending on the application. Moreover, it reduces cycle times, a critical gain for industries seeking to ramp up production speed.

Typical items being micro moulded using this technique can comprise a wide range of surgical, endoscopic, point of care testing, diabetes management, drug delivery and DNA research and sequencing devices. Additionally, the expanding market includes catheter components, hearing aids, dental prosthetics, microfluidics, vials, caps, specimen cups, vacuum blood and serum collection tubes, syringes, and IV parts.

To provide accurate and reliable process temperatures for equipment that is designed to operate at high temperatures creates a real challenge. It’s not only because of the extremely high operating temperatures required, but also because each composite and product being manufactured on the machine requires a very precise temperature level.

That said, laboratory equipment and diagnostics equipment remains clearly important. For these types of applications, manufacturers generally utilise larger machines within the IntElect series. The company is also closely monitoring the corona preventative agent market, including oral tablets and nasal administration pumping sprays.

There is just a handful of expert companies that would look at the manufacturer’s critical processes, and deliver a detailed, documented plan to keep his operations running. If it came to the worst and a chiller broke down, that partner should be able to say exactly what, when and where it happened and provide a solution to keep the plant up and running in matter of hours. Either by fixing the issue or providing a contingency solution to fill the gap. This is the part of the production that directly influences whether a plant can maintain the quality, keep their production running and keep their end customers satisfied.

Until recently, all the manufacturers could do with a standard TCU was setting a temperature range, flow rate and test it until the desired quality was achieved. The latest developments in the TCU’s designs, have brought precision temperature control to a new level, a level that allows the manufacturer not only to achieve the precise temperature, but is also reducing the power consumption of the system.

Our medical team can provide support and guidance right up until the Site Acceptance Test (SAT). Once configured with the mould tooling, automation and other periphery equipment, the customer assumes overall responsibility for the production cell. At that point really everything should have been checked with regard to the material influences and how the moulding machine performs.

Traditionally, a Temperature Control Unit (TCU) has three main functions – to heat, to cool and to control. It works alongside a process-grade chiller to provide enhanced cooling power, and at elevated temperatures provide accurate temperature control with minimum temperature deviation. It does so by regulating the heating elements contained within the TCU, teamed with the cooling capacity provided by the chiller.

To illustrate the impact, consider a manufacturing line currently producing a mould every 10 seconds. If the goal is to accelerate this pace to one mould every eight seconds for increased output, enhanced cooling is essential to expedite the solidification process. With speed control pumps on the TCUs, operators can fine-tune the desired ΔT and cooling levels, achieving precise control over the cooling process.

High profile acquisitions of diagnostics companies, IPO listings, advances in liquid blood testing technology provide further assurance that the diagnostics market is on the cusp of another huge growth curve. This all indicates that there are clearly exciting opportunities ahead for moulders operating in the high tech medical device and diagnostics product development and production space.

The medical market, particularly diagnostics, was strongly influenced by the Coronavirus pandemic. As expected, there has been a natural slow down in the consumable business related to the pandemic. Currently, there is a stronger leaning towards larger strategic and more complex projects, such as drug delivery devices and pen style injectors. This is due to the global growth in diabetes care.

There is a strong move towards “copy & paste” systems and processes in both Europe and North America. We are also seeing requests for remote system access to historical machine data for troubleshooting and monitoring validated process settings.

One thing all of these applications have in common is their need for total accuracy and zero defects during the moulding process.

A comparison between a system equipped with centrifugal pumps and utilising ΔT control, and a device featuring unregulated peripheral impeller pumps speaks volumes. In a three-shift operation, the contrast in annual electricity consumption is 14.495 kWh versus a mere 1.160 kWh with the new systems. For manufacturers operating multiple moulding machines with TCUs, the cumulative energy savings can be significant, contributing to both cost reduction and environmental sustainability.

As observed during the pandemic, the shift towards virtual appointments, larger scale adoption of home healthcare programmes and smart diagnostic devices is no longer seen as being untenable. For medical moulders already producing vital monitoring devices, e.g. oxygen, weight, glucose and ECG devices, as well as infusion pumps and cannulas etc. and already meeting the exacting healthcare standards, the transition to homecare device production should be relatively seamless.

Strict user parameters ensures that explicit ISO 13485 medical component quality assurance and validation standards are consistently adhered to. The key areas that might impact a stable process include changes in pressure, temperature, flow rate and cooling rates. If these are altered in any way without approval it can trigger a costly re-validation exercise.

Customers that cannot determine their needs can always draw upon our pool of medical experts to populate a document with the design detail. This consultancy support gives a level of transparency to all parties, helping to circumvent renegotiations later down the project line. Having a defined structure also enhances the overall production quality.

Process optimisation, enhanced productivity and TCO can have the biggest impact on profitability. Again, these are greatly enhanced by the high-performance drives. Confirmed by comprehensive lifetime tests performed on both the machines and components. Spindles tested under the toughest production conditions showed no signs of visible wear, even after millions of cycles.

Image

Home diagnostic and wellbeing solutions driven by the aging population and telehealth and outpatient care will inevitably direct future treatment pathways.

GETTING A QUOTE WITH LK-MOULD IS FREE AND SIMPLE.
TRY IT TODAY :

FIND MORE OF OUR SERVICES: